We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




WHO Working on Vaccine for Deadly Avian Flu

By Biotechdaily staff writers
Posted on 29 Jan 2004
To protect humans against a new strain of avian flu that has killed all five humans infected to date, the World Health Organization (Geneva, Switzerland) is moving forward with procedures to rapidly produce a new influenza vaccine.

The human deaths coincide with unprecedented epidemics in birds of the highly pathogenic H5N1 avian influenza in Viet Nam, Korea, and Japan. More...
The epidemic in birds is the first in Japan since 1925 and the first ever documented in Viet Nam and Korea.

Prototype viruses for vaccine production are being prepared by laboratories in the WHO Global Influenza Network. Laboratories in Hong Kong and Japan have isolated the virus from specimens obtained from two of the human fatal cases in Viet Nam. The virus is being analyzed at the molecular level to obtain information about its origin and its relationship to viruses currently circulating in birds and possibly other animals.

The studies will also determine the antigenic and genetic characteristics of the virus that are needed to produce a vaccine candidate. Using laboratories in the WHO influenza network and following procedures established by WHO to detect and respond to a new influenza virus subtype, a prototype virus could be made available to vaccine manufacturers within about four weeks.




Related Links:
World Health Organization (WHO)

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Aspiration System
VACUSAFE
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.